Treatment of Fluconazole-Refractory Thrush

Primary Treatment Options

The Infectious Diseases Society of America (IDSA) recommends itraconazole solution 200 mg once daily with strong evidence, demonstrating efficacy in 64-80% of fluconazole-refractory cases 1, 3
The IDSA also recommends posaconazole suspension 400 mg twice daily for 3 days, then 400 mg daily (up to 28 days) with strong evidence, achieving approximately 75% efficacy in refractory disease 1, 4

Voriconazole 200 mg twice daily for 7-14 days is an alternative with strong evidence, though it carries higher rates of adverse events including visual disturbances and phototoxicity 1, 2, 5
Amphotericin B deoxycholate oral suspension 100 mg/mL four times daily is another alternative, though less preferred due to tolerability issues (bitter taste, GI side effects) 1, 2

IV echinocandin, such as caspofungin (70 mg loading dose, then 50 mg daily), micafungin (100 mg daily), or anidulafungin (200 mg loading dose, then 100 mg daily), is recommended 1, 2, 4
IV amphotericin B deoxycholate 0.3 mg/kg daily is a less preferred alternative due to nephrotoxicity 1, 2

Obtain Candida species identification and antifungal susceptibility testing, critical in refractory cases to identify resistant organisms 6
Non-albicans species, particularly C. glabrata, may be azole-resistant and respond better to echinocandins or amphotericin B 6
Cross-resistance between fluconazole and itraconazole occurs in approximately 30% of fluconazole-resistant isolates 5

Standard duration is 7-14 days for oropharyngeal candidiasis, but may need extension to 14-21 days for severe or refractory cases 1, 6
Monitor for clinical response within 3-5 days - if no improvement, obtain fungal cultures and susceptibility testing 7
Treatment should continue for at least 48 hours after symptom resolution 8

Disinfection of dentures is mandatory in addition to antifungal therapy - failure to address this will result in treatment failure regardless of antifungal choice 1, 2, 8
Posaconazole and itraconazole have numerous drug-drug interactions that are particularly relevant in elderly patients on multiple medications 5
Check renal function before initiating therapy, as elderly patients often have reduced creatinine clearance requiring dose adjustments 7

Fluconazole 100 mg three times weekly is recommended for chronic suppression with strong evidence 1, 4, 3, 6

Do not continue nystatin - it has already failed and topical agents are inferior to systemic therapy for moderate-to-severe disease 1, 5, 8
Do not use ketoconazole - it is limited by hepatotoxicity and drug interactions and is not recommended 5
Do not use clotrimazole or miconazole for refractory disease - these are only appropriate for mild, initial episodes 1, 2
Do not use itraconazole capsules - only the oral solution formulation is effective for oropharyngeal candidiasis 5, 3